Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 1862(4): 526-535, 2016 04.
Artigo em Inglês | MEDLINE | ID: mdl-26820774

RESUMO

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease. Here we show that a mouse model of haploinsufficiency in the lipid and protein phosphatase and tensin homolog protein (PTEN(+/-)) exhibits hepatomegaly, increased liver lipogenic gene expression (SREBP-1C and PPARγ) and hepatic lesions analogous to human NAFLD. The livers of PTEN(+/-) mice also contained lower levels of retinoic acid (RA) than normal, similarly to human NAFLD patients. The RA signaling pathway thus offers a novel therapeutic target for the treatment of NAFLD although the impact of nutrition in this context is unclear. We therefore fed PTEN(+/-) mice for 36weeks a diet containing genetically engineered high-carotenoid corn (HCAR) to investigate its potential beneficial effects on the hepatic symptoms of NAFLD. The HCAR diet reduced hepatomegaly and promoted the repartitioning of fatty acids in the liver, away from triacylglycerol storage. At the molecular level, the HCAR diet clearly reduced lipogenic gene expression, boosted catabolism, and increased hepatic RA levels. These results set the stage for human trials to evaluate the use of high-carotenoid foods for the reduction or prevention of steatosis in NAFLD.


Assuntos
Carotenoides/farmacologia , Alimentos Geneticamente Modificados , Haploinsuficiência , Hepatomegalia/prevenção & controle , Hepatopatia Gordurosa não Alcoólica/prevenção & controle , PTEN Fosfo-Hidrolase/genética , Zea mays , Ração Animal , Animais , Feminino , Hepatomegalia/genética , Hepatomegalia/metabolismo , Hepatomegalia/patologia , Camundongos , Camundongos Mutantes , Hepatopatia Gordurosa não Alcoólica/genética , Hepatopatia Gordurosa não Alcoólica/metabolismo , Hepatopatia Gordurosa não Alcoólica/patologia , PPAR gama/genética , PPAR gama/metabolismo , PTEN Fosfo-Hidrolase/metabolismo , Proteína de Ligação a Elemento Regulador de Esterol 1/genética , Proteína de Ligação a Elemento Regulador de Esterol 1/metabolismo
2.
Int J Dev Biol ; 57(6-8): 565-76, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24166439

RESUMO

Metabolic engineering in plants can be used to increase the abundance of specific valuable metabolites, but single-point interventions generally do not improve the yields of target metabolites unless that product is immediately downstream of the intervention point and there is a plentiful supply of precursors. In many cases, an intervention is necessary at an early bottleneck, sometimes the first committed step in the pathway, but is often only successful in shifting the bottleneck downstream, sometimes also causing the accumulation of an undesirable metabolic intermediate. Occasionally it has been possible to induce multiple genes in a pathway by controlling the expression of a key regulator, such as a transcription factor, but this strategy is only possible if such master regulators exist and can be identified. A more robust approach is the simultaneous expression of multiple genes in the pathway, preferably representing every critical enzymatic step, therefore removing all bottlenecks and ensuring completely unrestricted metabolic flux. This approach requires the transfer of multiple enzyme-encoding genes to the recipient plant, which is achieved most efficiently if all genes are transferred at the same time. Here we review the state of the art in multigene transformation as applied to metabolic engineering in plants, highlighting some of the most significant recent advances in the field.


Assuntos
Engenharia Metabólica/métodos , Redes e Vias Metabólicas , Plantas Geneticamente Modificadas , Plantas/genética , Biotecnologia , DNA Bacteriano/genética , DNA de Plantas/genética , Enzimas/metabolismo , Ácidos Graxos Insaturados/metabolismo , Inativação Gênica , Técnicas de Transferência de Genes , Engenharia Genética/métodos , Fases de Leitura Aberta , Plantas Geneticamente Modificadas/genética , Plantas Geneticamente Modificadas/metabolismo , Biologia Sintética/métodos , Fatores de Transcrição/metabolismo , Transgenes
3.
Plant Mol Biol ; 83(1-2): 5-19, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23430566

RESUMO

Genetically engineered (GE) crops can be used as part of a combined strategy to address food insecurity, which is defined as a lack of sustainable access to safe and nutritious food. In this article, we discuss the causes and consequences of food insecurity in the developing world, and the indirect economic impact on industrialized countries. We dissect the healthcare costs and lost productivity caused by food insecurity, and evaluate the relative merits of different intervention programs including supplementation, fortification and the deployment of GE crops with higher yields and enhanced nutritional properties. We provide clear evidence for the numerous potential benefits of GE crops, particularly for small-scale and subsistence farmers. GE crops with enhanced yields and nutritional properties constitute a vital component of any comprehensive strategy to tackle poverty, hunger and malnutrition in developing countries and thus reduce the global negative economic effects of food insecurity.


Assuntos
Abastecimento de Alimentos/economia , Alimentos Geneticamente Modificados/economia , Engenharia Genética/métodos , Produtos Agrícolas/economia , Produtos Agrícolas/genética , Deficiências Nutricionais/economia , Atenção à Saúde/economia , Atenção à Saúde/organização & administração , Países em Desenvolvimento , Suplementos Nutricionais/economia , Oryza/economia , Oryza/genética , Pobreza/prevenção & controle , Zea mays/economia , Zea mays/genética
4.
Transgenic Res ; 22(2): 255-67, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23430588

RESUMO

A recent paper published in the journal Food and Chemical Toxicology presents the results of a long-term toxicity study related to a widely-used commercial herbicide (Roundup™) and a Roundup-tolerant genetically modified variety of maize, concluding that both the herbicide and the maize varieties are toxic. Here we discuss the many errors and inaccuracies in the published article resulting in highly misleading conclusions, whose publication in the scientific literature and in the wider media has caused damage to the credibility of science and researchers in the field. We and many others have criticized the study, and in particular the manner in which the experiments were planned, implemented, analyzed, interpreted and communicated. The study appeared to sweep aside all known benchmarks of scientific good practice and, more importantly, to ignore the minimal standards of scientific and ethical conduct in particular concerning the humane treatment of experimental animals.


Assuntos
Neoplasias/etiologia , Má Conduta Científica/ética , Zea mays/genética , Animais , Diversidade Cultural , Tolerância a Medicamentos/genética , Alimentos Geneticamente Modificados/toxicidade , Glicina/análogos & derivados , Glicina/química , Herbicidas/química , Neoplasias/induzido quimicamente , Ratos , Ciência/ética , Zea mays/toxicidade , Glifosato
5.
Genes Nutr ; 8(1): 29-41, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22926437

RESUMO

Malnutrition is a prevalent and entrenched global socioeconomic challenge that reflects the combined impact of poverty, poor access to food, inefficient food distribution infrastructure, and an over-reliance on subsistence mono-agriculture. The dependence on staple cereals lacking many essential nutrients means that malnutrition is endemic in developing countries. Most individuals lack diverse diets and are therefore exposed to nutrient deficiencies. Plant biotechnology could play a major role in combating malnutrition through the engineering of nutritionally enhanced crops. In this article, we discuss different approaches that can enhance the nutritional content of staple crops by genetic engineering (GE) as well as the functionality and safety assessments required before nutritionally enhanced GE crops can be deployed in the field. We also consider major constraints that hinder the adoption of GE technology at different levels and suggest policies that could be adopted to accelerate the deployment of nutritionally enhanced GE crops within a multicomponent strategy to combat malnutrition.

6.
Plant Biotechnol J ; 11(2): 129-41, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22970850

RESUMO

Antioxidants are protective molecules that neutralize reactive oxygen species and prevent oxidative damage to cellular components such as membranes, proteins and nucleic acids, therefore reducing the rate of cell death and hence the effects of ageing and ageing-related diseases. The fortification of food with antioxidants represents an overlap between two diverse environments, namely fortification of staple foods with essential nutrients that happen to have antioxidant properties (e.g. vitamins C and E) and the fortification of luxury foods with health-promoting but non-essential antioxidants such as flavonoids as part of the nutraceuticals/functional foods industry. Although processed foods can be artificially fortified with vitamins, minerals and nutraceuticals, a more sustainable approach is to introduce the traits for such health-promoting compounds at source, an approach known as biofortification. Regardless of the target compound, the same challenges arise when considering the biofortification of plants with antioxidants, that is the need to modulate endogenous metabolic pathways to increase the production of specific antioxidants without affecting plant growth and development and without collateral effects on other metabolic pathways. These challenges become even more intricate as we move from the engineering of individual pathways to several pathways simultaneously. In this review, we consider the state of the art in antioxidant biofortification and discuss the challenges that remain to be overcome in the development of nutritionally complete and health-promoting functional foods.


Assuntos
Antioxidantes/metabolismo , Produtos Agrícolas/química , Alimentos Fortificados , Engenharia Genética , Ácido Ascórbico/biossíntese , Carotenoides/biossíntese , Produtos Agrícolas/genética , Flavonoides/biossíntese , Alimentos Orgânicos , Alimento Funcional , Melatonina/biossíntese , Valor Nutritivo , Plantas Geneticamente Modificadas/química , Plantas Geneticamente Modificadas/genética , Ubiquinona/análogos & derivados , Ubiquinona/biossíntese
7.
Plant Biotechnol J ; 10(9): 1026-34, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22928600

RESUMO

Multivitamin corn is a novel genetically engineered variety that simultaneously produces high levels of ß-carotene, ascorbate and folate, and therefore has the potential to address simultaneously multiple micronutrient deficiencies caused by the lack of vitamins A, B9 and C in developing country populations. As part of the development process for genetically engineered crops and following European Food Safety Authority (EFSA) recommendations, multivitamin corn must be tested in whole food/feed sub-chronic animal feeding studies to ensure there are no adverse effects, and potential allergens must be identified. We carried out a 28-day toxicity assessment in mice, which showed no short-term sub-acute evidence of diet-related adverse health effects and no difference in clinical markers (food consumption, body weight, organ/tissue weight, haematological and biochemical blood parameters and histopathology) compared to mice fed on a control diet. A subsequent 90-day sub-chronic feeding study again showed no indications of toxicity compared to mice fed on control diets. Our data confirm that diets enriched with multivitamin corn have no adverse effects on mice, do not induce any clinical signs of toxicity and do not contain known allergens.


Assuntos
Plantas Geneticamente Modificadas/toxicidade , Vitaminas/administração & dosagem , Zea mays/toxicidade , Animais , Feminino , Masculino , Camundongos , Testes de Toxicidade Subaguda , Testes de Toxicidade Subcrônica , Vitaminas/toxicidade
8.
Plant Cell Rep ; 30(3): 249-65, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21249369

RESUMO

The eight Millennium Development Goals (MDGs) are international development targets for the year 2015 that aim to achieve relative improvements in the standards of health, socioeconomic status and education in the world's poorest countries. Many of the challenges addressed by the MDGs reflect the direct or indirect consequences of subsistence agriculture in the developing world, and hence, plant biotechnology has an important role to play in helping to achieve MDG targets. In this opinion article, we discuss each of the MDGs in turn, provide examples to show how plant biotechnology may be able to accelerate progress towards the stated MDG objectives, and offer our opinion on the likelihood of such technology being implemented. In combination with other strategies, plant biotechnology can make a contribution towards sustainable development in the future although the extent to which progress can be made in today's political climate depends on how we deal with current barriers to adoption.


Assuntos
Biotecnologia/tendências , Objetivos , Plantas , Síndrome da Imunodeficiência Adquirida/prevenção & controle , Síndrome da Imunodeficiência Adquirida/terapia , Adulto , Criança , Mortalidade da Criança/tendências , Conservação dos Recursos Naturais , Países em Desenvolvimento , Educação , Feminino , Saúde Global , Humanos , Fome , Cooperação Internacional , Malária/prevenção & controle , Malária/terapia , Masculino , Desnutrição/prevenção & controle , Bem-Estar Materno/tendências , Doenças das Plantas/prevenção & controle , Plantas/genética , Plantas Geneticamente Modificadas/genética , Pobreza/prevenção & controle , Tuberculose/prevenção & controle , Tuberculose/terapia , Nações Unidas , Vacinas/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...